Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

AMAR
Amarillo Biosciences, Inc. Common Stock
stock OTC

Inactive
May 21, 2021
0.6001USD-14.271%(-0.0999)6,107
Pre-market
0.00USD-100.000%(-0.70)0
After-hours
0.00USD0.000%(0.00)0
OverviewHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Sep 10, 2020
01:22PM EDT  via NEWMEDIAWIRE -- Amarillo Biosciences, Inc. (ABI or the Company), (AMAR), the world leader in low-dose non-injectable interferon research, is pleased to announce the appointment of Dr. Manfred Beilharz, Associate Professor at The University of Western Australia and renown pioneer in interferon research, to the Companys Scientific Advisory Board.   GlobeNewswire Inc
Aug 13, 2020
02:46PM EDT  Amarillo Biosciences to Reaffirm Low-Dose Interferon Research   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC